YOUR BUSINESS AUTHORITY
Springfield, MO
AstraZeneca has acquired St. Louis-based vaccine bioconjugation specialist Omniose.
Omniose is now a wholly owned subsidiary within AstraZeneca's infectious disease unit.
“Omniose’s bioconjugation platform represents a differentiated approach to engineering conjugate vaccines and strengthens our ability to develop novel vaccines against serious bacterial infections,” said Benjamin Moutier, senior vice president, infectious disease at AstraZeneca.
Read more from Fierce Biotech.
This is a multi-phase project, with a new addition as well as renovations to the current church facility that include expanding the current parking lot, according to construction officials.
Former OMB Bank officer placed on probation
Flurry of trades made by O'Reilly Automotive officials in early November
Stark Caverns breaks ground on $11M adventure park in Lake of the Ozarks
Bolton’s General Store named Most Neighborly Business by MU Extension
Trump administration announces $480M loan for Gulf of America project
Giving circle issues nearly $115K in grants
Construction worker launches AI platform to connect job seekers, projects